Spectinomycin hydrochloride anhydrous
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281669This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 296JEI210Z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, but more generally known as spectinomycin hydrochloride anhydrous, which bears US NIH Compound Identifier 3033928. European Medicines Agency schedules spectinomycin hydrochloride anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10614MIG. Most nations, for tariff purposes, schedule spectinomycin hydrochloride anhydrous under HS 29419000. Spectinomycin hydrochloride anhydrous bears US NLM identifiers UMLS ID C2983839 and NCI Concept Code C90690. SMILES: C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.CL.CL.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.